To enhance the selectivity and specificity of Tat-KLA peptide for tumour cells, it was conjugated to the BRBP1 peptide (12 AA) which was previously identified to possess affinity for human breast cancer cells MDA-MB-231 that metastasize to the brain and where they were renamed 231-BR cells [70]. The gene discussed is KL; the disease is neoplasm.